Alerts will be sent to your verified email
Verify EmailUNICHEMLAB
Unichem Lab
|
Orchid Pharma
|
Gufic Biosciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
41.0 . | n/a | n/a |
Number of ANDA's Approved By USFDA
|
27.0 . | n/a | n/a |
R&D as a % of Total Sales
|
7.38 % | n/a | 0.83 % |
Financials
|
|||
5 yr Average ROE
|
-2.21 % | -4.13 % | 25.05 % |
5yr average Equity Multiplier
|
1.28 | 1.73 | 2.22 |
5yr Average Asset Turnover Ratio
|
0.42 | 0.45 | 1.05 |
5yr Avg Net Profit Margin
|
-3.85 % | -7.02 % | 10.9 % |
Price to Book
|
1.8 | 3.46 | 6.54 |
P/E
|
0.0 | 38.36 | 45.81 |
5yr Avg Cash Conversion Cycle
|
80.33 Days | 49.11 Days | 26.94 Days |
Inventory Days
|
146.44 Days | 112.59 Days | 66.86 Days |
Days Receivable
|
128.35 Days | 91.49 Days | 128.09 Days |
Days Payable
|
225.53 Days | 201.52 Days | 163.91 Days |
5yr Average Interest Coverage Ratio
|
-0.08 | -0.51 | 13.1 |
5yr Avg ROCE
|
-0.47 % | 0.51 % | 27.25 % |
5yr Avg Operating Profit Margin
|
2.2 % | 10.69 % | 18.45 % |
5 yr average Debt to Equity
|
0.09 | 0.49 | 0.51 |
5yr CAGR Net Profit
|
3.21 % | n/a | 14.26 % |
5yr Average Return on Assets
|
-1.68 % | -1.77 % | 11.52 % |
Shareholdings
|
|||
Promoter Holding
|
70.22 % | 69.84 % | 72.51 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
19.29 % | -20.16 % | -2.97 % |
Change in Mutual Fund Holding (3 Yrs)
|
1.71 % | 16.34 % | 2.36 % |
Unichem Lab
|
Orchid Pharma
|
Gufic Biosciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|